3 completed, 1 unknown. 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Leukemia, Acute Lymphocytic (ALL): new trials by email Literature Review of Leukemia, Acute Lymphocytic (ALL) trials Research Report on Leukemia, Acute Lymphocytic (ALL)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS Chimeric antigen receptor T cells, peptide specific dendritic cell - Leukemia, Acute Lymphocytic (ALL), Leukemia, Acute Myelogenous (AML) | Phase 1 | Unknown | Zhujiang Hospital | 30 | 2018-05-05 | 2024-03-15 |
| Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood WT1 Peptide-Pulsed Dendritic Cells, Donor Lymphocytes, IL-4 - Leukemia, Acute Myelogenous (AML), Leukemia, Acute Lymphocytic (ALL) | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 10 | 2008-02-22 | 2017-04-12 |
| Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies CliniMACS, Stem cell transplantation, Fludarabine - Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML) | Phase 2 | Completed | St. Jude Children's Research Hospital | 73 | 2007-12-14 | 2020-04-14 |
| Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies Miltenyi Biotec CliniMACS, Stem Cell Transplantation, TBI, systemic chemotherapy and antibodies as follows: - Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML) | Phase 3 | Completed | St. Jude Children's Research Hospital | 57 | 2002-03-01 | 2009-01-29 |
Leukemia (4) · Leukemia, Myeloid, Acute (4) · Myelodysplastic Syndromes (4) · Lymphoma, Non-Hodgkin (3) · Hemoglobinuria (2) · Hemoglobinuria, Paroxysmal (2) · Hodgkin Disease (2) · Leukemia, Myelomonocytic, Juvenile (2) · Lymphoma (2) · Hematologic Neoplasms (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Bone Marrow Diseases (4) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Leukemia, Myeloid (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Pathological Conditions, Signs and Symptoms (3) · Anemia (2) · Anemia, Hemolytic (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2)
Stem Cell Transplantation (2) · Acetaminophen (1) · Alemtuzumab (1) · Antibodies (1) · Antilymphocyte Serum (1) · Cyclophosphamide (1) · Diphenhydramine (1) · Endotoxins (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Immunotherapy, Adoptive (1) · Interleukin-4 (1) · Melphalan (1) · Muromonab-CD3 (1) · Mycophenolic Acid (1)
St. Jude Children's Research Hospital (2) · National Cancer Institute (NCI) (1) · Zhujiang Hospital (1)
United States (3) · China (1)
Brandon Triplett, MD (1) · Gregory A. Hale, M.D. (1) · Terry J Fry, M.D. (1) · Yuhua Li, M.D, Ph.D (1)